CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Shares withheld for taxes CBO & COO gave up 3,112 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 2,360 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise Chief Executive Officer acquired 17,750 shares (option exercise)
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Chief Executive Officer gave up 37,818 shares (to pay taxes)
- 4 Shares withheld for taxes CBO & COO gave up 11,185 shares (to pay taxes)
- 4 Shares withheld for taxes Executive VP, Head of R&D gave up 12,607 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 6,303 shares (to pay taxes)
- 4 Option exercise General Counsel and Secretary acquired 7,342 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
Page 18 of 45 · 883 filings